List of Excipients in API buprenorphine and naloxone
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing buprenorphine and naloxone
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| BioDelivery Sciences International Inc | BUNAVAIL | buprenorphine and naloxone | 59385-012 | .ALPHA.-TOCOPHEROL ACETATE | |
| BioDelivery Sciences International Inc | BUNAVAIL | buprenorphine and naloxone | 59385-012 | ANHYDROUS CITRIC ACID | |
| BioDelivery Sciences International Inc | BUNAVAIL | buprenorphine and naloxone | 59385-012 | CARBOXYMETHYLCELLULOSE SODIUM | |
| BioDelivery Sciences International Inc | BUNAVAIL | buprenorphine and naloxone | 59385-012 | DIBASIC POTASSIUM PHOSPHATE | |
| BioDelivery Sciences International Inc | BUNAVAIL | buprenorphine and naloxone | 59385-012 | FERRIC OXIDE YELLOW | |
| BioDelivery Sciences International Inc | BUNAVAIL | buprenorphine and naloxone | 59385-012 | HYDROXYETHYL CELLULOSE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing buprenorphine and naloxone
Detailed excipient profiles for buprenorphine and naloxone
Excipient focus: .ALPHA.-TOCOPHEROL
buprenorphine and naloxone drug variants containing .ALPHA.-TOCOPHEROL
buprenorphine and naloxone drug variants not containing .ALPHA.-TOCOPHEROL
Excipient focus: .ALPHA.-TOCOPHEROL ACETATE
buprenorphine and naloxone drug variants containing .ALPHA.-TOCOPHEROL ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing .ALPHA.-TOCOPHEROL ACETATE
Excipient focus: ACESULFAME POTASSIUM
buprenorphine and naloxone drug variants containing ACESULFAME POTASSIUM
buprenorphine and naloxone drug variants not containing ACESULFAME POTASSIUM
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
Excipient focus: ALCOHOL
buprenorphine and naloxone drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| Almatica Pharma Inc | buprenorphine and naloxone | 52427-692 |
| Redpharm Drug | buprenorphine and naloxone | 67296-1933 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing ALCOHOL
Excipient focus: AMMONIA
buprenorphine and naloxone drug variants containing AMMONIA
buprenorphine and naloxone drug variants not containing AMMONIA
Excipient focus: ANHYDROUS CITRIC ACID
buprenorphine and naloxone drug variants containing ANHYDROUS CITRIC ACID
buprenorphine and naloxone drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: BUTYL ALCOHOL
buprenorphine and naloxone drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| Almatica Pharma Inc | buprenorphine and naloxone | 52427-692 |
| Redpharm Drug | buprenorphine and naloxone | 67296-1933 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing BUTYL ALCOHOL
Excipient focus: BUTYLATED HYDROXYANISOLE
buprenorphine and naloxone drug variants containing BUTYLATED HYDROXYANISOLE
buprenorphine and naloxone drug variants not containing BUTYLATED HYDROXYANISOLE
Excipient focus: BUTYLATED HYDROXYTOLUENE
buprenorphine and naloxone drug variants containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-580 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing BUTYLATED HYDROXYTOLUENE
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
buprenorphine and naloxone drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
Excipient focus: CITRIC ACID ACETATE
buprenorphine and naloxone drug variants containing CITRIC ACID ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | buprenorphine and naloxone | 62175-452 |
| REMEDYREPACK INC | buprenorphine and naloxone | 70518-2311 |
| Bryant Ranch Prepack | buprenorphine and naloxone | 71335-1296 |
| Bryant Ranch Prepack | buprenorphine and naloxone | 71335-1378 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing CITRIC ACID ACETATE
Excipient focus: CITRIC ACID MONOHYDRATE
buprenorphine and naloxone drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| Almatica Pharma Inc | buprenorphine and naloxone | 52427-692 |
| Bryant Ranch Prepack | buprenorphine and naloxone | 63629-4028 |
| Redpharm Drug | buprenorphine and naloxone | 67296-1933 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: CORN SYRUP
buprenorphine and naloxone drug variants containing CORN SYRUP
buprenorphine and naloxone drug variants not containing CORN SYRUP
Excipient focus: CROSPOVIDONE
buprenorphine and naloxone drug variants containing CROSPOVIDONE
buprenorphine and naloxone drug variants not containing CROSPOVIDONE
Excipient focus: DIBASIC POTASSIUM PHOSPHATE
buprenorphine and naloxone drug variants containing DIBASIC POTASSIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing DIBASIC POTASSIUM PHOSPHATE
Excipient focus: FD&C BLUE NO. 1
buprenorphine and naloxone drug variants containing FD&C BLUE NO. 1
buprenorphine and naloxone drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C RED NO. 40
buprenorphine and naloxone drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | buprenorphine and naloxone | 62175-452 |
| REMEDYREPACK INC | buprenorphine and naloxone | 70518-2311 |
| Bryant Ranch Prepack | buprenorphine and naloxone | 71335-1296 |
| Bryant Ranch Prepack | buprenorphine and naloxone | 71335-1378 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
buprenorphine and naloxone drug variants containing FD&C YELLOW NO. 6
buprenorphine and naloxone drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE YELLOW
buprenorphine and naloxone drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: HYDROXYETHYL CELLULOSE
buprenorphine and naloxone drug variants containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing HYDROXYETHYL CELLULOSE
Excipient focus: HYDROXYPROPYL CELLULOSE
buprenorphine and naloxone drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE 2910
buprenorphine and naloxone drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| Redpharm drug | buprenorphine and naloxone | 67296-1877 |
| Redpharm Drug | buprenorphine and naloxone | 67296-2063 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
buprenorphine and naloxone drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | buprenorphine and naloxone | 63629-4028 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing HYPROMELLOSES
Excipient focus: ISOPROPYL ALCOHOL
buprenorphine and naloxone drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| Almatica Pharma Inc | buprenorphine and naloxone | 52427-692 |
| Redpharm Drug | buprenorphine and naloxone | 67296-1933 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: LACTOSE MONOHYDRATE
buprenorphine and naloxone drug variants containing LACTOSE MONOHYDRATE
buprenorphine and naloxone drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
buprenorphine and naloxone drug variants containing MAGNESIUM STEARATE
buprenorphine and naloxone drug variants not containing MAGNESIUM STEARATE
Excipient focus: MALTITOL
buprenorphine and naloxone drug variants containing MALTITOL
buprenorphine and naloxone drug variants not containing MALTITOL
Excipient focus: MALTODEXTRIN
buprenorphine and naloxone drug variants containing MALTODEXTRIN
buprenorphine and naloxone drug variants not containing MALTODEXTRIN
Excipient focus: MANNITOL
buprenorphine and naloxone drug variants containing MANNITOL
buprenorphine and naloxone drug variants not containing MANNITOL
Excipient focus: METHYLPARABEN
buprenorphine and naloxone drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing METHYLPARABEN
Excipient focus: POLYCARBOPHIL
buprenorphine and naloxone drug variants containing POLYCARBOPHIL
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing POLYCARBOPHIL
Excipient focus: POLYETHYLENE GLYCOL
buprenorphine and naloxone drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-580 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 8000
buprenorphine and naloxone drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| Redpharm drug | buprenorphine and naloxone | 67296-1877 |
| Redpharm Drug | buprenorphine and naloxone | 67296-2063 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYETHYLENE GLYCOLS
buprenorphine and naloxone drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | buprenorphine and naloxone | 63629-4028 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: POLYETHYLENE OXIDE 100000
buprenorphine and naloxone drug variants containing POLYETHYLENE OXIDE 100000
buprenorphine and naloxone drug variants not containing POLYETHYLENE OXIDE 100000
Excipient focus: POLYETHYLENE OXIDE 1000000
buprenorphine and naloxone drug variants containing POLYETHYLENE OXIDE 1000000
buprenorphine and naloxone drug variants not containing POLYETHYLENE OXIDE 1000000
Excipient focus: POLYETHYLENE OXIDE 200000
buprenorphine and naloxone drug variants containing POLYETHYLENE OXIDE 200000
buprenorphine and naloxone drug variants not containing POLYETHYLENE OXIDE 200000
Excipient focus: POLYETHYLENE OXIDE 2000000
buprenorphine and naloxone drug variants containing POLYETHYLENE OXIDE 2000000
buprenorphine and naloxone drug variants not containing POLYETHYLENE OXIDE 2000000
Excipient focus: POLYETHYLENE OXIDE 900000
buprenorphine and naloxone drug variants containing POLYETHYLENE OXIDE 900000
buprenorphine and naloxone drug variants not containing POLYETHYLENE OXIDE 900000
Excipient focus: POTASSIUM HYDROXIDE
buprenorphine and naloxone drug variants containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| Almatica Pharma Inc | buprenorphine and naloxone | 52427-692 |
| Redpharm Drug | buprenorphine and naloxone | 67296-1933 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing POTASSIUM HYDROXIDE
Excipient focus: POVIDONE
buprenorphine and naloxone drug variants containing POVIDONE
buprenorphine and naloxone drug variants not containing POVIDONE
Excipient focus: POVIDONE K29/32
buprenorphine and naloxone drug variants containing POVIDONE K29/32
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-580 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing POVIDONE K29/32
Excipient focus: POVIDONE K30
buprenorphine and naloxone drug variants containing POVIDONE K30
buprenorphine and naloxone drug variants not containing POVIDONE K30
Excipient focus: PROPYLENE GLYCOL
buprenorphine and naloxone drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| Almatica Pharma Inc | buprenorphine and naloxone | 52427-692 |
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| Redpharm Drug | buprenorphine and naloxone | 67296-1933 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing PROPYLENE GLYCOL
Excipient focus: PROPYLPARABEN
buprenorphine and naloxone drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing PROPYLPARABEN
Excipient focus: SACCHARIN SODIUM
buprenorphine and naloxone drug variants containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing SACCHARIN SODIUM
Excipient focus: SHELLAC
buprenorphine and naloxone drug variants containing SHELLAC
buprenorphine and naloxone drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
buprenorphine and naloxone drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | buprenorphine and naloxone | 62175-452 |
| REMEDYREPACK INC | buprenorphine and naloxone | 70518-2311 |
| Bryant Ranch Prepack | buprenorphine and naloxone | 71335-1296 |
| Bryant Ranch Prepack | buprenorphine and naloxone | 71335-1378 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM BENZOATE
buprenorphine and naloxone drug variants containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing SODIUM BENZOATE
Excipient focus: SODIUM CITRATE
buprenorphine and naloxone drug variants containing SODIUM CITRATE
buprenorphine and naloxone drug variants not containing SODIUM CITRATE
Excipient focus: SODIUM HYDROXIDE
buprenorphine and naloxone drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM METABISULFITE
buprenorphine and naloxone drug variants containing SODIUM METABISULFITE
buprenorphine and naloxone drug variants not containing SODIUM METABISULFITE
Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
buprenorphine and naloxone drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-580 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
Excipient focus: SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
buprenorphine and naloxone drug variants containing SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Excipient focus: STARCH, CORN
buprenorphine and naloxone drug variants containing STARCH, CORN
buprenorphine and naloxone drug variants not containing STARCH, CORN
Excipient focus: SUCRALOSE
buprenorphine and naloxone drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| >Company | >Ingredient | >NDC |
buprenorphine and naloxone drug variants not containing SUCRALOSE
Excipient focus: TITANIUM DIOXIDE
buprenorphine and naloxone drug variants containing TITANIUM DIOXIDE
buprenorphine and naloxone drug variants not containing TITANIUM DIOXIDE
Excipient focus: TRISODIUM CITRATE DIHYDRATE
buprenorphine and naloxone drug variants containing TRISODIUM CITRATE DIHYDRATE
buprenorphine and naloxone drug variants not containing TRISODIUM CITRATE DIHYDRATE
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links